Name: Latest research reports of Lupin Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Lupin Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

2182.2000 -8.70 (-0.40%)

NSE Jan 09, 2026 15:31 PM

New 52W High in past week

Volume: 929.5K

Lupin Ltd.

16 Dec 2024

2182.20

-0.40%

Lupin (BUY): Reduction in in-licence portfolio to increase margins

Buy: Lupin Ltd.

BOB Capital Markets Ltd.

LPC's domestic region in-licence portfolio fell from 15% in Q2FY24 to 12% in Q2FY25 and is expected to reduce further to ~10% by FY26

Lupin Ltd. has an average target of 2328.00 from 10 brokers.